Indivior Finalizes $300M Deal To End Suboxone Cases
Pharmaceutical manufacturer Indivior has finalized an agreement to pay a total of $300 million to all 50 states to settle allegations it falsely and aggressively marketed the opioid-based drug Suboxone, an...To view the full article, register now.
Already a subscriber? Click here to view full article